Stephanie is a Senior Trial Manager for the ECAL trial; which is a large (target N= 1250) multi-centre, phase III, Randomised Controlled Trial (RCT) assessing is the effectiveness, cost effectiveness and safety of e-cigarettes (ECs) compared with combination nicotine replacement therapy (NRT) as an aid to smoking cessation for patients with chronic obstructive pulmonary disease (COPD).
Stephanie has over 10 years of experience in research and clinical trials. Her experience spans all phases of the research cycle; from research governance, Research Facilitator and Trial Management. She has worked on a variety of clinical trials to GCP standards